General Other

ABT Stock: Quarterly Beat Arrives On Base Business As Covid Testing Demand Falls

ABT Stock: Quarterly Beat Arrives On Base Business As Covid Testing Demand Falls

Abbott Laboratories (ABT) on Thursday reported adjusted earnings of $1.17 per share on $10.2 billion in sales for its second quarter. But ABT stock dipped a fraction.




X

Advertisement




On average, analysts polled by FactSet expected Abbott to earn $1.02 per share on $9.69 billion in sales.

In the year-earlier period, Abbott earnings were 57 cents a share on $7.33 billion in sales.

For the year, Abbott predicts adjusted profit of $4.30-$4.50 per share. Analysts called for adjusted profit of $4.36 per share and $39.39 billion in sales.

In premarket trading on the stock market today, ABT stock fell 0.2% near 118.80.

More to follow.

Follow Allison Gatlin on Twitter at @IBD_AGatlin.

YOU MAY ALSO LIKE:

Johnson & Johnson Shrugs Off Vaccine Worries But Stays Flat Despite Quarterly Beat

Intuitive Surgical Stock Nears $1,000 As The Covid Recovery Continues

IBD’s Leaderboard Is Celebrating 10 Years!

Options Trading: How To Start Using Options, How To Manage Risk

IBD Stock Of The Day: See How To Find, Track And Buy The Best Stocks

Advertisement

About the author

mm

Shawn Utley

Shawn previously worked as a journalist for several local newspapers until he realized the potential of internet for news reporting. He joined the team as a contributor which provided him a platform to dedicate his experience and knowledge for a wider range of audience. He excels in curating business news for the website.

Add Comment

Click here to post a comment

Your email address will not be published. Required fields are marked *